-
Symbol
-
CARM on OTC
-
Investment type
-
Equity / Common Stock, $0.001 par value per share
-
Latest Disclosed Shares Owned
-
1,855,871 shares
-
Security Ownership %
-
4.4%
AbbVie Biotechnology Ltd. ownership in Carisma Therapeutics Inc. Common Stock, $0.001 par value per share (CARM)
25 Apr 2025 - AbbVie Biotechnology Ltd. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 1,855,871 shares of Carisma Therapeutics Inc. Common Stock, $0.001 par value per share (CARM).
This represents 4.4% ownership of the company.
This is the first filing by AbbVie Biotechnology Ltd disclosing ownership of Carisma Therapeutics Inc. Common Stock, $0.001 par value per share (CARM).